Palatin Technologies
PTN
#9855
Rank
S$47.7 M
Marketcap
S$28.02
Share price
5.26%
Change (1 day)
2,342.85%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -S$6.57 Million

According to Palatin Technologies's latest financial reports the company's current earnings are S$8.84 Million. In 2024 the company made an earning of -S$34.31 Million, an increase over its 2023 earnings that were of -S$41.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$6.57 Million-80.86%
2024 -S$34.31 Million-16.9%
2023 -S$41.29 Million5.99%
2022 -S$38.96 Million-13.7%
2021 -S$45.14 Million33.25%
2020 -S$33.88 Million-172.11%
2019 S$46.97 M2352.33%
2018 S$1.91 M-94.13%
2017 S$32.64 M-154.92%
2016 -S$59.43 Million3.67%
2015 -S$57.33 Million878%
2014 -S$5.87 Million-72.64%
2013 -S$21.43 Million-33.11%
2012 -S$32.03 Million77.71%
2011 -S$18.03 Million
2003 -S$30.52 Million29.93%
2002 -S$23.49 Million36.18%
2001 -S$17.25 Million
1999 -S$14.32 Million6.04%
1998 -S$13.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.25 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.67 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$0.74 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.29 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$85.06 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.15 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$64.38 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-S$37.56 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-S$70.75 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA